COLLPLANT BIOTECHNOLOGIES LTD发布2025年第三季度财务报告

投资观察
Nov 26

11月26日 - COLLPLANT BIOTECHNOLOGIES LTD在其2025年第三季度财务报告中指出:*COLLPLANT BIOTECHNOLOGIES 9个月的运营支出为1000万美元*COLLPLANT BIOTECHNOLOGIES 9个月的调整后净收入为-700万美元*COLLPLANT BIOTECHNOLOGIES 9个月的调整后每股收益为-0.58美元*COLLPLANT BIOTECHNOLOGIES 9个月的收入为230万美元*COLLPLANT BIOTECHNOLOGIES 9个月的净收入为-830万美元*COLLPLANT BIOTECHNOLOGIES 9个月的每股收益为-0.69美元*COLLPLANT BIOTECHNOLOGIES LTD最近更新了支出预测,并已启动成本削减及裁员计划*COLLPLANT BIOTECHNOLOGIES:资源分配的更新将导致约25%的员工减少*COLLPLANT BIOTECHNOLOGIES LTD - ROGER POMERANTZ辞去董事会主席职务;YEHIEL TAL被提名为临时主席*COLLPLANT BIOTECHNOLOGIES LTD - ROGER POMERANTZ辞去董事会主席职务;YEHIEL TAL被提名为临时主席。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10